There are also medical conditions where weight-loss drugs would not be recommended, including a history of medullary thyroid cancer, pancreatitis, gastroparesis, or a family history of MEN2 (multiple endocrine neoplasia syndrome type 2
Merck's MK-0893, Lilly's LY2409021, and Pfizer's PF-06291874 all reached Phase 2 and all failed - transaminase elevations, LDL increases, weight gain
This dual-action approach helps: Appetite Regulation : GLP-1 works on the appetite centers in the brain to reduce hunger signals
Additionally, factors secreted by retinal cells, like IL-6, promote the proliferation of different retinal cell types, contributing to the formation of new blood vessels and the progression of diabetic retinopathy (84)